The Estée Lauder Companies (ELC) unveiled new scientific findings at the 2026 IMCAS World Congress to help reinforce its “leadership position” in the longevity arena.
The US beauty giant attended the annual gathering for dermatology, plastic surgery and aesthetics in Paris, France, which took place between 29 to 31 January, to present fresh insights into sirtuin and exosome research.
Dr Rishabh Kala, Lead Scientist for Estée Lauder, and Dr Jaime Emmetsberger, Lead Scientist for La Mer’s Max Huber Research Labs, were selected by the company’s Scientific Committee to deliver talks on ELC’s skin longevity and regenerative aesthetics, respectively.
During the event, Kala spoke on sirtuins – a group of seven proteins that are strongly associated with healthy ageing and longevity.
These are said to help regulate how cells use energy, respond to stress and maintain balance over time.
“Estée Lauder’s proprietary research demonstrates the ability of exclusive ingredients to counteract the effects of age-related declines in sirtuin activity,” ELC said in a statement.
“By supporting visible age reversal and improved skin resilience, the company is continuing to advance skin longevity, helping skin cells perform at their peak and act younger and healthier for longer.”
Emmetsberger, meanwhile, highlighted exosomes as a rapidly emerging area of interest in cosmetic science.
During the event, she noted that the term exosome is often applied too broadly, leading to confusion and suggested clearer standards to address this.
She also highlighted a growing shift toward more scalable options from plants, algae and the microbiome, which are increasingly relevant for cosmetic applications.
“We are honoured to have two of our expert scientists selected to present at the 2026 IMCAS World Congress, an achievement that reflects the strength of our Global Research and Innovation organisation,” said Claude Saliou, Senior VP, Advanced Technologies and Global Clinical & Consumer Science, at ELC.
“Their research underscores our company’s long-standing leadership in skin longevity and regenerative aesthetics, exemplifying our ability to translate cutting-edge discovery into transformative beauty innovations.”
ELC has been doubling down its focus on longevity science in recent years.
In May 2025, ELC teamed up with the Hacienda AltaGracia hotel in Costa Rica to open the latest iteration of its experiential concept, Skin Longevity Institute.
The brand has opened Institute retail concepts in UK department store Harrods, as well as sites in China and Montreal.
ELC also partnered with biotechnology company Serpin Pharma to explore longevity skin care innovations.
The companies are working together to research the efficacy of mitigating harmful inflammation and enhancing cell resiliency.
Previously, ELC has partnered with the Stanford Center on Longevity to fund research into longevity.
Related content:
- L'Oréal's masterplan to take longevity beauty mainstream
- Vichy wants to ‘lead’ in integrative health – and cracking nutricosmetics is key
- Lancôme to launch longevity skin care range powered by mitochondria-rejuvenating Mitopure
- Is longevity the next big beauty category?
- Is ‘longevity washing’ beauty's next big issue?
- Estée Lauder unveils longevity-focused pop-up at South Korea’s Incheon Airport
- Estée Lauder opens Skin Longevity Institute in Costa Rica
- Estée Lauder Companies bets on longevity with Serpin Pharma partnership
- Estée Lauder targets age reversal with Stanford Center on Longevity partnership